Zheng-Wu Peng, stands at the forefront of neuropsychiatric research as an Associate Research Fellow and Associate Chief Technician at Xijing Hospital, the prestigious First Affiliated Hospital of Air Force Medical University. In his multifaceted role encompassing Associate Professor, Master's Degree Supervisor, and Principal Investigator of the Behavioral Laboratory, he has cultivated a dynamic research environment where cutting-edge science meets clinical innovation. His academic journey culminated in an M.D. from Air Force Medical University, where he subsequently earned distinction as a Young Talent of Fourth Military Medical University—a testament to his exceptional promise early in his career. Driven by an unwavering commitment to unraveling the mysteries of affective disorders, Dr. Peng serves as a core member of the Shaanxi Provincial University Youth Innovation Team, spearheading groundbreaking investigations into biological mechanisms and prevention strategies. His innovative research agenda focuses on elucidating the complex interplay between neural circuits and emotional regulation, with the ultimate goal of developing novel therapeutic interventions for patients suffering from depression, anxiety, and related conditions. Through rigorous preclinical studies and well-designed clinical trials, his team continues to push the boundaries of translational neuroscience. His influence extends far beyond the laboratory through active leadership in multiple professional organizations. As Executive Committee Member of the Shaanxi Psychological Professional Committee, he helps shape regional mental health policies and practice standards. His expertise in neuromodulation is recognized nationally through his committee membership in the Chinese Medical Doctor Association, where he contributes to advancing non-invasive brain stimulation techniques. Additionally, his appointment to the Brain Disease Cellular and Molecular Medicine Professional Committee of the Shaanxi Society of Cell Biology reflects his interdisciplinary approach to understanding brain disorders at multiple biological levels. With remarkable scholarly productivity, Dr. Peng has built an impressive funding portfolio that underscores his research independence and collaborative spirit. As Principal Investigator, he has successfully secured three competitive grants from the National Natural Science Foundation of China, alongside seven additional research projects. His willingness to engage in meaningful scientific collaboration is evident through his participation in seventeen NSFC projects and over forty other research grants as Co-Investigator. Furthermore, he has registered and currently leads five clinical trials, demonstrating his dedication to translating laboratory discoveries into tangible patient benefits. Dr. Peng's research output has made substantial impact on the international scientific community. His publication record exceeds 150 peer-reviewed articles, including 50 SCI papers where he served as first or corresponding author. These contributions have garnered significant recognition, as reflected in his impressive h-index of 28—a metric indicating both the quantity and quality of his scholarly influence. Beyond traditional academic outputs, he holds eight authorized utility model patents that protect innovative technologies arising from his research. His commitment to knowledge dissemination is further evidenced by four co-authored monographs that serve as important educational resources for students and professionals alike. Through this diverse portfolio of achievements, Dr. Peng continues to advance the frontiers of neuropsychiatric research while training the next generation of scientific leaders.